Barclays Maintains Equal-Weight on Medpace Holdings, Lowers Price Target to $450
Benzinga Newsdesk 6 months ago
NewsPrice TargetAnalyst Ratings
Barclays analyst Luke Sergott maintains Medpace Holdings (NASDAQ:MEDP) with a Equal-Weight and lowers the price target from $500 to $450.
Barclays analyst Luke Sergott maintains Medpace Holdings (NASDAQ:MEDP) with a Equal-Weight and lowers the price target from $500 to $450.